Edition:
United States

People: Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

16.66USD
2 Dec 2016
Change (% chg)

-- (--)
Prev Close
$16.66
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,821,446
52-wk High
$44.57
52-wk Low
$15.92

Lanchbury, Jerry 

Dr. Jerry S. Lanchbury Ph.D. is Chief Scientific Officer of Myriad Genetics, Inc. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named Chief Scientific Officer in February 2010. Dr. Lanchbury came to us from GKT School of Medicine, King’s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1st Class Honours, B.Sc. “Biology of Man & his Environment” degree from the University of Aston.

Basic Compensation

Total Annual Compensation, USD 644,514
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,521,430
Fiscal Year Total, USD 3,165,950

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 105,786 2,156,310.00